K. Matsuura et al., Amidase and peptidase activities of polyclonal immunoglobulin G present inthe sera of patients with rheumatoid arthritis, APPL BIOC B, 83(1-3), 2000, pp. 107-113
Polyclonal Immunoglobulin (Ig) G from patients with rheumatoid arthritis (R
A) and healthy subjects hydrolyzed carbobenzoxy-val-Gly-Arg p-nitroanilide
and D-Pro-Phe-Arg p-nitroanilide. RA IgG exhibited higher activity against
the former substrate, but not the latter. On the other hand, RA IgG showed
reduced activity against D-Pro-Phe-Arg methylcoumarinamide, when compared w
ith those of the healthy controls. These results suggest that RA IgGs diffe
r from normal IgGs in the substrate specificity of amidase activity. Prelim
inary studies have shown that two out of three RA IgG samples cleaved a pen
tapeptide-Gln-Arg-Arg-Ala-Ala-which is assumed to be associated with the ri
sk of developing RA (Gregersen, P. K. et al. (1987), Arthritis Rheum. 30, 1
205-1213). By contrast, virtually no cleavage of the same peptide was obser
ved with IgG from healthy controls. A peptide analog, Gln-Arg-Arg-Trp-Ala,
was not cleaved at all by any IgGs examined either from RA patients or heal
thy controls.